Page last updated: 2024-10-23

seratrodast and Bronchitis

seratrodast has been researched along with Bronchitis in 1 studies

Bronchitis: Inflammation of the large airways in the lung including any part of the BRONCHI, from the PRIMARY BRONCHI to the TERTIARY BRONCHI.

Research Excerpts

ExcerptRelevanceReference
"The effects of the orally active thromboxane A2 (TxA2) receptor antagonist seratrodast and the cysteinyl leukotrienes (cLTs) receptor antagonist pranlukast on cough response to inhaled capsaicin were examined in sixteen patients with stable chronic bronchitis."5.10Thromboxane antagonism and cough in chronic bronchitis. ( Fujimura, M; Ishiura, Y; Kurashima, K; Myou, S; Nobata, K; Takegoshi, T; Yamamori, C, 2003)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ishiura, Y1
Fujimura, M1
Yamamori, C1
Nobata, K1
Myou, S1
Kurashima, K1
Takegoshi, T1

Trials

1 trial available for seratrodast and Bronchitis

ArticleYear
Thromboxane antagonism and cough in chronic bronchitis.
    Annals of medicine, 2003, Volume: 35, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Benzoquinones; Bronchitis; Capsaicin; Chromones; Chronic Disease; Co

2003